Abstract
Histone deacetylase (HDAC) inhibitors have emerged as a new class of anticancer agents, targeting the biological processes including cell cycle, apoptosis and differentiation. In the present study, a series of 1,3,4-thiadiazole based hydroxamic acids were developed as potent HDAC inhibitors. Some of them showed good inhibitory activity in HDAC enzyme assay and potent growth inhibition in some tumor cell lines. Among them, compound 6i (IC(50) = 0.089 μM), exhibited better inhibitory effect compared with SAHA (IC(50) = 0.15 μM).
Citations
Feb 15, 2014·Bioorganic & Medicinal Chemistry·Leiqiang HanHao Fang
Sep 2, 2014·Chemical & Pharmaceutical Bulletin·Feng RenNa Jin
Nov 3, 2015·ACS Combinatorial Science·Seung-Ju YangYoung-Dae Gong
Sep 12, 2013·Journal of Enzyme Inhibition and Medicinal Chemistry·Nguyen-Hai NamSang-Bae Han
Jul 5, 2015·European Journal of Medicinal Chemistry·Romeo RomagnoliFrancisco Estévez
Jul 1, 2016·ACS Combinatorial Science·Seung-Ju YangYoung-Dae Gong
Jul 26, 2016·BMC Pharmacology & Toxicology·Yan-Xin HuangYu-Xin Li
May 11, 2017·Chemical Biology & Drug Design·Yi ZhouHao Fang
Dec 28, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mehlika Dilek AltıntopAhmet Özdemir
May 11, 2018·Anti-cancer Agents in Medicinal Chemistry·Mehlika D AltıntopZafer A Kaplancıklı
Oct 3, 2017·SAR and QSAR in Environmental Research·M ManalM J N Chandrasekar
Sep 4, 2020·Pharmacological Reports : PR·Monika Szeliga
Oct 22, 2020·Antibiotics·Min Woo HaSeung-Mann Paek
Aug 20, 2019·Bioorganic & Medicinal Chemistry·Patrick M WehrliJohan Gottfries
Jul 7, 2021·Bioorganic Chemistry·Christiana MantzouraniGeorge Kokotos
Apr 11, 2014·Chemical Reviews·Yang HuHai-Liang Zhu
Jan 9, 2018·ACS Combinatorial Science·Ji-Eun HaYoung-Dae Gong